TRVI
Trevi Therapeutics Inc
NASDAQ · Pharmaceuticals
$11.46
+0.52 (+4.75%)
Open$11.19
Previous Close$10.94
Day High$11.81
Day Low$11.01
52W High$14.39
52W Low$3.77
Volume—
Avg Volume1.64M
Market Cap1.47B
P/E Ratio—
EPS$-0.37
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+91.4% upside
Current
$11.46
$11.46
Target
$21.93
$21.93
$18.04
$21.93 avg
$33.12
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 772.80M | 683.27M | 746.33M |
| Net Income | 98.54M | 104.02M | 99.75M |
| Profit Margin | 12.8% | 15.2% | 13.4% |
| EBITDA | 196.14M | 177.32M | 185.79M |
| Free Cash Flow | 50.24M | 55.58M | 60.41M |
| Rev Growth | +0.7% | +7.7% | +15.7% |
| Debt/Equity | 0.64 | 0.66 | 0.70 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |